Do you think there's any chance they have already come to an...

First 2 Last

Share
Profile

Follow
loloagain

180 Posts.

22/08/14

16:00

Post #: 13858918
Share

Originally posted by MACLEOD22 ↑

Today Genorah/Nkwe are off to the courts over the Tubatse farms.

COURT B
15. Bengwenyama-Ya-Maswazi Community & others v Minister for Mineral Resources & others - 783/2013
Judges: Navsa ADP , Brand JA, Shongwe JA, Majiedt JA, Schoeman AJA

and

16. Bengwenyama-Ya-Maswazi Community & others v - Genorah Resources (Pty) Ltd & others - 784/2013 (GNP)
Judges: Navsa ADP, Brand JA, Shongwe JA, Majiedt JA, Schoeman AJA

The court will be in session very soon. I have been granted access to the Heads of Arguments by the Court but unfortunately due to the large size of the files they cannot be emailed to me. Very disappointed.

The good news is that judgements appear to be handed down much earlier than I was originally advised. We may see a decision within a fortnight based upon past practice.

The Supreme Court of Appeal advises......."Witnesses do not appear before the court, and the parties need not be present during the hearing of an appeal. A written judgment is usually handed down shortly after the argument"

Expand

Do you think there's any chance they have already come to an agreement and just have to front the hearing to have it ratified?

Such a prospect would fit conveniently with the late Quarterly being due 25th.

Thanks for the heads up as well.

NKP Price at posting: 6.1¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug